Capital Guardian Trust’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-178
Closed -$8K – 437
2018
Q3
$8K Buy
+178
New +$7.6K ﹤0.01% 481
2017
Q2
– Sell
-2,000
Closed -$91K – 494
2017
Q1
$91K Sell
2,000
-212
-10% -$8.99K ﹤0.01% 395
2016
Q4
$89K Buy
2,212
+2,011
+1,000% +$79.2K ﹤0.01% 412
2016
Q3
$8K Buy
+201
New +$8.06K ﹤0.01% 598
2015
Q2
– Sell
-170
Closed -$9K – 762
2015
Q1
$9K Sell
170
-830
-83% -$39.7K ﹤0.01% 625
2014
Q4
$46K Sell
1,000
-204
-17% -$9.9K ﹤0.01% 410
2014
Q3
$68K Sell
1,204
-436
-27% -$23.4K ﹤0.01% 376
2014
Q2
$87K Buy
1,640
+640
+64% +$34K ﹤0.01% 352
2014
Q1
$52K Buy
+1,000
New +$50.6K ﹤0.01% 380

Other funds holding SNY

Capital Guardian Trust's SNY Position: Q4 2018 in Review

Capital Guardian Trust sold out of Sanofi (SNY) in Q4 2018, closing a stake of 178 shares — an estimated $8K sold.

Capital Guardian Trust first reported a position in SNY in Q1 2014 and held it in 9 quarters. The position peaked at $91K in Q1 2017. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

  • Capital Guardian Trust reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
  • Capital Guardian Trust sold 178 Sanofi shares in Q4 2018, an estimated $8K.
  • Capital Guardian Trust first reported a position in Sanofi in Q1 2014 and held it in 9 quarters.
  • Capital Guardian Trust's Sanofi position peaked at $91K in Q1 2017.
  • 501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on Capital Guardian Trust's 13F filing for Q4 2018, filed 14 Feb 2019.